Skip to main content
. Author manuscript; available in PMC: 2012 Jul 1.
Published in final edited form as: Pharm Res. 2010 Nov 30;28(7):1480–1499. doi: 10.1007/s11095-010-0325-1

Fig. 5.

Fig. 5

A Site-specific immobilization of cutinase-fusion proteins using an active site-directed capture ligand. B Structure of F. solani cutinase enzyme free and bound to the inhibitor n-undecyl-O-methyl phosphonate chloride. The inhibitor is covalently bound through the side-chain hydroxyl group of the Ser120 residue, which is located at the active site of the enzyme (113).